clinical trials for tirzepatide New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Tirzepatide for Medical Weight Loss

Interestingly, some patients experience improved sleep quality as a result of weight loss and better glycemic control on tirzepatide

The Stress-Glutathione Connection Chronic physical and emotional stress are major contributors to glutathione depletion, increasing your bodys demand

As one report notes, GLP-1 peptide manufacturing anchors the first amino acid to [polystyrene] beads and relies on coupling reagents and solvents that challenge green chemistry goals ( [20] )

Fatigue: Some researchers report temporary fatigue during the first few days, which may reflect the body increased healing activity diverting energy resources toward tissue repair

Jessica Folek, M.D., director of bariatric surgery for Northwell Healths Long Island Jewish Forest Hills Hospital in New York City